Home

Elevance Health, Inc. Common Stock (ELV)

347.84
-2.41 (-0.69%)
NYSE · Last Trade: Jul 4th, 11:05 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close350.25
Open355.01
Bid348.00
Ask352.30
Day's Range347.21 - 357.24
52 Week Range347.21 - 567.26
Volume2,006,214
Market Cap80.93B
PE Ratio (TTM)13.54
EPS (TTM)25.7
Dividend & Yield6.840 (1.97%)
1 Month Average Volume1,748,036

Chart

News & Press Releases

Elevance Health (NYSE: ELV) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
PHILADELPHIA, July 03, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the “Class Period”).
By Berger Montague · Via GlobeNewswire · July 3, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · July 3, 2025
Jim Cramer On Centene's 40% Crash: Fewer ACA Signups, Sicker Patients, Pulled Guidance And Major Earnings Hit Trigger Selloff: 'This Is Horrifying'benzinga.com
Shares of managed care provider Centene Corp. (NYSE: CNC) dropped over 40% on Wednesday, marking the worst single-day performance in the company's history.
Via Benzinga · July 3, 2025
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2025 Results on July 17
Elevance Health (NYSE: ELV) will release second quarter 2025 financial results on July 17, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
By Elevance Health, Inc. · Via Business Wire · July 2, 2025
Which S&P500 stocks are moving on Wednesday?chartmill.com
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
Via Chartmill · July 2, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · July 2, 2025
Unusual volume S&P500 stocks in Wednesday's sessionchartmill.com
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.
Via Chartmill · July 2, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill · July 2, 2025
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · July 2, 2025
These S&P500 stocks are gapping in today's sessionchartmill.com
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.
Via Chartmill · July 2, 2025
Wondering what's happening in today's S&P500 pre-market session?chartmill.com
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
Via Chartmill · July 2, 2025
ELV CLASS REMINDER: Elevance Health, Inc. is Being Sued for Securities Fraud - Contact BFA Law by July 11 if You Suffered Losses
NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws.
Via ACCESS Newswire · July 1, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · July 1, 2025
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Compass Diversified (NYSE:CODI), Digimarc Corporation (NASDAQ:DMRC), Elevance Health, Inc. (NYSE:ELV), and West Pharmaceutical Services, Inc. (NYSE:WST). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · June 30, 2025
ELV DEADLINE REMINDER: Elevance Health, Inc. Investors Are Reminded of The Approaching July 11 Legal Deadline - Contact BFA Law if You Lost Money
NEW YORK CITY, NY / ACCESS Newswire / June 30, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws.
Via ACCESS Newswire · June 30, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK CITY, NY / ACCESS Newswire / June 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Via ACCESS Newswire · June 30, 2025
ELV Deadline: Rosen Law Firm Urges Elevance Health, Inc. (NYSE: ELV) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024, and October 16, 2024. Elevance describes itself as a “healthcare company that provides health insurance plans to a variety of markets.”
By The Rosen Law Firm, P.A. · Via Business Wire · June 28, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · June 28, 2025
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · June 28, 2025
ELV DEADLINE NOTICE: Elevance Health, Inc. Investors that Suffered Losses are Notified of the July 11 Class Action Deadline -- Contact BFA Law
NEW YORK, NY / ACCESS Newswire / June 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws.
Via ACCESS Newswire · June 27, 2025
ELV SECURITIES NOTICE: Elevance Health, Inc. Investors may have been Affected by Fraud - Contact BFA Law by July 11 if You Suffered Losses
NEW YORK CITY, NY / ACCESS Newswire / June 26, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws.
Via ACCESS Newswire · June 26, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK CITY, NY / ACCESS Newswire / June 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Via ACCESS Newswire · June 26, 2025
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · June 25, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK CITY, NY / ACCESS Newswire / June 25, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Via ACCESS Newswire · June 25, 2025
BFA Law Notifies Elevance Health, Inc. (ELV) Investors that the Company was Sued for Fraud - Contact the Firm by July 11 if You Lost Money
NEW YORK CITY, NY / ACCESS Newswire / June 25, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws.
Via ACCESS Newswire · June 25, 2025